NASDAQ

Progenics Pharmaceuticals Sets Second Quarter 2016 Financial Results Call for August 4

TARRYTOWN, N.Y., July 22, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology ...

Heat Biologics Announces Suspension of Proposed Public Offering of Common Stock

DURHAM, N.C., July 22, 2016 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), an ...

Heat Biologics Announces Proposed Public Offering of Common Stock

DURHAM, N.C., July 21, 2016 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), an immuno-oncology ...

TESARO to Announce Second-Quarter 2016 Financial Results on August 4, 2016

WALTHAM, Mass., July 21, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce its ...

Adamis Pharmaceuticals Provides Update On License Agreement with Allergan plc 

SAN DIEGO, July 21, 2016 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) (“Company” or “Adamis”) ...

Adamis Pharmaceuticals Provides Update On License Agreement with Allergan plc 

SAN DIEGO, July 21, 2016 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) (“Company” or “Adamis”) ...

Molecular Health Strengthens U.S. Based Executive Management Team

Appoints Gerry Sheridan as Chief Financial Officer Appoints Dr. Les Paul as Chief Medical ...

Momenta Pharmaceuticals Announces Date for Second Quarter 2016 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., July 21, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology ...

Galenica and Relypsa Announce Agreement for Galenica to Acquire Relypsa

– Acquisition Strengthens Galenica’s Business Unit, Vifor Pharma – Galenica will commence a tender offer ...